Catherine Ramsey
Stock Analyst at Baird
(3.46)
# 780
Out of 4,814 analysts
44
Total ratings
36.36%
Success rate
8.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
WAT Waters | Upgrades: Outperform | $396 → $407 | $321.12 | +26.74% | 8 | Mar 26, 2025 | |
ILMN Illumina | Maintains: Neutral | $127 → $90 | $71.16 | +26.48% | 5 | Mar 5, 2025 | |
NTRA Natera | Maintains: Outperform | $183 → $188 | $148.08 | +26.96% | 6 | Feb 28, 2025 | |
CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $21.53 | +71.89% | 8 | Feb 28, 2025 | |
TWST Twist Bioscience | Maintains: Outperform | $48 → $54 | $39.50 | +36.71% | 6 | Feb 4, 2025 | |
RVTY Revvity | Maintains: Outperform | $136 → $138 | $95.54 | +44.44% | 3 | Nov 5, 2024 | |
TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $436.79 | +52.25% | 2 | Nov 1, 2022 | |
A Agilent Technologies | Maintains: Outperform | $155 → $160 | $102.47 | +56.14% | 5 | Aug 17, 2022 | |
EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $41.59 | +80.35% | 1 | Aug 3, 2022 |
Waters
Mar 26, 2025
Upgrades: Outperform
Price Target: $396 → $407
Current: $321.12
Upside: +26.74%
Illumina
Mar 5, 2025
Maintains: Neutral
Price Target: $127 → $90
Current: $71.16
Upside: +26.48%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $148.08
Upside: +26.96%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $21.53
Upside: +71.89%
Twist Bioscience
Feb 4, 2025
Maintains: Outperform
Price Target: $48 → $54
Current: $39.50
Upside: +36.71%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $136 → $138
Current: $95.54
Upside: +44.44%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $436.79
Upside: +52.25%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $102.47
Upside: +56.14%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $41.59
Upside: +80.35%